IDEAYA Biosciences, Inc.

30J.SG·Stuttgart·Healthcare
Compare
28.46−0.85 (−2.90%)today
As of Oct 30, 9:55 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close29.31
Open29.32
Day range28.3529.36
52-week range23.3936.46
Off day high−3.07%
Off 52-week high−21.94%
Volume0.00
Avg. volume (3M)12.00
Market cap2.75B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.04
Shares outstanding96.49M
Short interest—
Earnings date—
Analyst target—
Profit margin−74.75%

Against its peers

Compare in full ›
30J.SG RCUS 9966.HK 688382.SS IOVA IMCR
Market cap — 2.40B 6.43B 8.38B 3.75B 1.51B
P/E (TTM) — — — — — —
Forward P/E — -6.1 -21.0 -43.8 -42.3 -37.7
Price/book — 3.8 3.3 6.6 5.1 3.6
Dividend yield — — — — — —
1-year change — −1.28% −39.84% −48.70% +276.62% −7.49%
Today −2.90% −1.32% +1.68% +4.33% −4.77% −2.66%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 30J.SG news ›
Stock Titan·Positive

IDEAYA Biosciences CEO sells 26,338 shares

3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area Merck…

@PRNewswire·Positive

IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma

Oct 19, 2026, 06:00 ET Prior tebentafusp (2L) (N=15) All presentations will take place on Saturday, October 24th, 2026, 12:00-12:45pm (CEST): 2092P (Poster Presentation)Title: Neoadjuvant Darovasertib in Primary Uveal Melanoma: Follow-Up…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance